Advertisement

Glucose Allostasis

  1. Michael Stumvoll,
  2. P. Antonio Tataranni,
  3. Norbert Stefan,
  4. Barbora Vozarova and
  5. Clifton Bogardus
  1. From the Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona

    Abstract

    In many organisms, normoglycemia is achieved by a tight coupling of nutrient-stimulated insulin secretion in the pancreatic β-cell (acute insulin response [AIR]) and the metabolic action of insulin to stimulate glucose disposal (insulin action [M]). It is widely accepted that in healthy individuals with normal glucose tolerance, normoglycemia can always be maintained by compensatorily increasing AIR in response to decreasing M (and vice versa). This has been mathematically described by the hyperbolic relationship between AIR and M and referred to as glucose homeostasis, with glucose concentration assumed to remain constant along the hyperbola. Conceivably, glucose is one of the signals stimulating AIR in response to decreasing M. Hypothetically, as with any normally functioning feed-forward system, AIR should not fully compensate for worsening M, since this would remove the stimulus for the compensation. We provide evidence from cross-sectional, longitudinal, and prospective data from Pima Indians (n = 413) and Caucasians (n = 60) that fasting and postprandial glucose concentrations increase with decreasing M despite normal compensation of AIR. For this physiologic adaptation to chronic stress (insulin resistance), we propose to use the term “glucose allostasis.” Allostasis (stability through change) ensures the continued homeostatic response (stability through staying the same) to acute stress at some cumulative costs to the system. With increasing severity and over time, the allostatic load (increase in glycemia) may have pathological consequences, such as the development of type 2 diabetes.

    Footnotes

    • Address correspondence and reprint requests to Michael Stumvoll, MD, Clinical Diabetes and Nutrition Section, National Institutes of Health, 4212 N. 16th St., Phoenix, AZ 85016. E-mail: michael.stumvoll{at}med.uni-tuebingen.de.

      Received for publication 14 August 2002 and accepted in revised form 18 December 2002.

      AIR, acute insulin response; BCDI, β-cell demand index; CIR, corrected insulin response; DI, disposition index; IVGTT, intravenous glucose tolerance tests; M, insulin action; NGT, normal glucose tolerance; OGTT, oral glucose tolerance test.

    | Table of Contents
    Advertisement